長崎大学　高度感染症研究センター
ウイルス感染動態研究分野

研究業績 (2017年以降)

原著論文

  1. Anupong S, Chadsuthi S, Hongsing P, Hurst C, Phattharapornjaroen P, Rad S M AH, Fernandez S, Huang AT, Vatanaprasan P, Saethang T, Luk-In S, Storer RJ, Ounjai P, Devanga Ragupathi NK, Kanthawee P, Ngamwongsatit N, Badavath VN, Thuptimdang W, Leelahavanichkul A, Kanjanabuch T, Miyanaga K, Cui L, Nanbo A, Shibuya K, Kupwiwat R, Sano D, Furukawa T, Sei K, Higgins PG, Kicic A, Singer AC, Chatsuwan T, Trowsdale S, Abe S, Ishikawa H, Amarasiri M, Modchang C, Wannigama DL. Exploring indoor and outdoor dust as a potential tool for detection and monitoring of COVID-19 transmission. iScience., 26;27(3):109043, doi: 10.1016/j.isci.2024. 2024
  2. Dochi H, Kondo S, Komura S, Moriyama-Kita M, Komori T, Nanbo A, Sakaguchi M, Fukuyo M, Hamabe-Horiike T, Tanaka M, Mizokami H, Kano M, Kitagawa Y, Kobayashi E, Hirai N, Ueno T, Nakanishi Y, Endo K, Sugimoto H, Hanayama R, Kaneda A, Yoshizaki T. Peritumoral SPARC expression induced by exosomes from nasopharyngeal carcinoma infected Epstein-Barr virus: A poor prognostic marker. Int J Cancer., 1;154(5):895-911, doi: 10.1002/ijc.34777. 2024
  3. Wannigama DL, Amarasiri M, Phattharapornjaroen P, Hurst C, Modchang C, Chadsuthi S, Anupong S, Miyanaga K, Cui L, Fernandez S, Huang AT, Ounjai P, Tacharoenmuang R, Ragupathi NKD, Sano D, Furukawa T, Sei K, Leelahavanichkul A, Kanjanabuch T, Higgins PG, Nanbo A, Kicic A, Singer AC, Chatsuwan T, Trowsdale S, Khatib A, Shibuya K, Abe S, Ishikawa H, Hongsing P. Pathogen Hunters Research Team. Tracing the new SARS-CoV-2 variant BA.2.86 in the community through wastewater surveillance in Bangkok, Thailand. Lancet Infect Dis., 23(11):e464-e466. doi: 10.1016/S1473-3099(23)00620-5, 2024
  4. Wannigama DL, Amarasiri M, Phattharapornjaroen P, Hurst C, Modchang C, Chadsuthi S, Anupong S, Miyanaga K, Cui L, Thuptimdang W, Ali Hosseini Rad SM, Fernandez S, Huang AT, Vatanaprasan P, Jay DJ, Saethang T, Luk-In S, Storer RJ, Ounjai P, Ragupathi NKD, Kanthawee P, Sano D, Furukawa T, Sei K, Leelahavanichkul A, Kanjanabuch T, Higgins PG, Nanbo A, Kicic A, Singer AC, Chatsuwan T, Trowsdale S, Siow R, Shibuya K, Abe S, Ishikawa H, Hongsing P. Tracing the transmission of mpox through wastewater surveillance in Southeast Asia. J Travel Med., 5;30(5):taad096. doi: 10.1093/jtm/taad096. 2023
  5. Satoh AO, Fujioka Y, Kashiwagi S, Yoshida A,; Fujioka M, Sasajima H, Nanbo A, Amano M, Ohba Y. Interaction Between PI3K and the VDAC2 Channel Tethers Ras-PI3K-positive Endosomes to Mitochondria and Promotes Endosome Maturation, Cell Reports, 28;42(3):112229. doi: 10.1016/j.celrep.2023.112229. 2023
  6. Furuyama W, Sakaguchi M, Yamada K, Nanbo A. Development of an imaging system for visualization of Ebola virus glycoprotein throughout the viral lifecycle. Front Microbiol., 3;13:1026644, 2022
  7. Dochi H, Kondo S, Murata T, Fukuyo M, Nanbo A, Wakae K, Jiang WP, Hamabe-Horiike T, Tanaka M, Nishiuchi T, Mizokami H, Moriyama-Kita M, Kobayashi E, Hirai N, Komori T, Ueno T, Nakanishi Y, Hatano M, Endo K, Sugimoto H, Wakisaka N, Juang SH, Muramatsu M, Kaneda A, Yoshizaki T. Estrogen induces the expression of EBV lytic protein ZEBRA, a marker of poor prognosis in nasopharyngeal carcinoma, Cancer Sci., 113(8):2862-2877, 2022
  8. Yamaki K, Ohta K, Kobayashi N, Morita I, Kiguchi Y, Oyama H, Ito K, Nanbo A, Oh-Oka H, Koyama Y, Kawata Y, Fujisawa H, Ohta M. Purification of Emu IgY for Therapeutic and Diagnostic Use Based on Monoclonal Secondary Antibodies Specific to Emu IgY, Biol Pharm Bull, 45(8):1022-1026, 2022
  9. Isono M, Furuyama W, Kuroda M, Kondoh T, Igarashi M, Kajihara M, Yoshida R, Manzoor R, Okuya K, Miyamoto H, Feldmann H, Marzi A, Sakaitani M, Nanbo A, Takada A. A biaryl sulfonamide derivative as a novel inhibitor of filovirus infection, Antivir Res, 183:104932, 2020.
  10. Zhao M, Nanbo A, Becnel D, Qin Z, Morris G, Li L, Lin Z. Ubiquitin Modification of the Epstein-Barr Virus Immediate Early Transactivator Zta, J Virol, 94(22):e01298-20, 2020
  11. Furuyama W, Nanbo A, Maruyama J, Marzi A, Takada A. A complement component C1q-mediated mechanism of antibody-dependent enhancement of Ebola virus infection, PLoS Negl Trop Dis, 14(9):e0008602, 2020
  12. Nanbo A. Epstein-Barr Virus Exploits the Secretory Pathway to Release Virions, Microorganisms. 8(5):729, 2020
  13. Kheir F, Zhao M, Strong MJ, Yu Y, Nanbo A, Flemington EK, Morris GF, Reiss K, Li L, Lin Z. Detection of Epstein-Barr Virus Infection in Non-Small Cell Lung Cancer. Cancers 1. pii: E759, 2019
  14. Fujioka Y, Satoh AO, Horiuchi K, Fujioka M, Tsutsumi K, Sasaki J, Nepal P, Kashiwagi S, Paudel S, Nishide S, Nanbo A, Sasaki T, Ohba Y. A Peptide Derived from Phosphoinositide 3-kinase Inhibits Endocytosis and Influenza Virus Infection. Cell Struct Funct, 44:61-74, 2019
  15. Nanbo A, Ohba Y. Budding of Ebola virus particles requires the Rab11-dependent endocytic recycling pathway. J Infect Dis, 218. suppl_5 S388 S396, 2018
  16. Nanbo A, Katano H, Kataoka M, Hoshina S, Sekizuka T, Kuroda M, Ohba Y. Infection of Epstein–Barr Virus in Type III Latency Modulates Biogenesis of Exosomes and the Expression Profile of Exosomal miRNAs in the Burkitt Lymphoma Mutu Cell Lines. Cancers, 10(7). pii: E237, 2018
  17. Fujioka Y, Nishide S, Ose T, Kato U, Fukuhara H, Fujioka M, Horiuchi K, Satoh AO, Nepal P, Kashiwagi S，Wang J, Horiguchi M, Paudel S, Nanbo A, Miyazaki T, Maenaka K, Ohba Y. Influenza A Virus Entry into Mammalian Cells Requires A Voltage-Dependent Ca2+ Channel. Cell Host Microbe, 23(6): 809-818.e5, 2018
  18. Nanbo A, Ohashi M, Yoshiyama H, Ohba Y. The role of tumor growth factor β in cell-to-cell contact-mediated Epstein-Barr virus transmission. Front Microbio, 9, 984, 2018
  19. Nanbo A, Noda T, Ohba Y. Epstein–Barr Virus Acquires Its Final Envelope on Intracellular Compartments With Golgi Markers, Front Microbiol, 9, 454, 2018
  20. Nanbo A, Maruyama J, Imai M, Ujie M, Fujioka Y, Nishide S, Takada A, Ohba Y, Kawaoka Y. Ebola virus requires a host scramblase for externalization of phosphatidylserine on the surface of viral particles, PLoS Pathog, 14(1):e1006848. 2018

総説

  1. 古山若呼, 南保明日香. 海外BSL-4施設紹介 2022年12月、ウイルス, 72(2), p139-148
  2. 南保明日香, 浦田秀造, 津田祥美. 長崎大学BSL-4施設使用にかかる教育訓練プログラム開発への取り組み 2022年12月、ウイルス, 72(2), p125-130
  3. 南保明日香. 長崎市医師会報生涯教育シリーズ、エボラウイルス病と治療法開発の現状について 2022年5月号、p15-21
  4. Becnel D, Abdelghani R, Nanbo A, Avilala J, Kahn J, Li L, Lin Z. Pathogenic Role of Epstein-Barr Virus in Lung Cancers. Viruses., 13(5):877. 2021.
  5. Nanbo A, Furuyama W, Lin Z. RNA Virus-Encoded miRNAs: Current Insights and Future Challenges. Front Microbiol., 24 (12):679210. 2021
  6. Avilala J, Becnel D, Abdelghani R, Nanbo A, Kahn J, Li L, Lin Z. Role of Virally Encoded Circular RNAs in the Pathogenicity of Human Oncogenic Viruses. Front Microbiol. 12:657036. 2021.
  7. 南保明日香. エボラウイルス粒子へのホスファチジルセリン集積の分子機構の解明, Journal of the Society of Japanese Women Scientists, 2020 年 20 巻 1 号 p1-8
  8. Nanbo A, Kawaoka Y. Molecular Mechanism of Externalization of Phosphatidylserine on the Surface of Ebola Virus Particles. DNA Cell Biol., 38(2), 115-120, 2019
  9. Zhao M, Nanbo A, Sun L, Lin Z. Extracellular Vesicles in Epstein-Barr Virus' Life Cycle and Pathogenesis. Microorganisms., 7(2). pii: E48, 2019
  10. Kolesnikova L, Nanbo A, Kawaoka Y, Becker S. Inside the Cell. Curr Top Microbiol Immunol., 411:353-380, 2017

書籍

  1. 南保明日香. EBウイルスによるBリンパ球不死化機構(改訂第2版)，p90-94（柳井秀雄編：EBウイルス関連胃癌 ，診断と治療社出版，東京），2022
  2. 南保明日香. エボラウイルス侵入のプロセス, 創薬研究者が押さえておくべきウイルス学（技術情報協会）, 2021